CVE-2023-46360
Hardy Barth cPH2 eCharge Ladestation v1.87.0 and earlier is vulnerable to Execution with...
Hardy Barth cPH2 eCharge Ladestation v1.87.0 and earlier is vulnerable to Execution with Unnecessary Privileges.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- Low
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
NVD Score used
8.8
Hardy Barth cPH2 eCharge Ladestation v1.87.0 and earlier is vulnerable to Execution with Unnecessary Privileges.
- Record
CVE-2023-46360- CVSS 3.1
- 8.8 High
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-250
- Updated
- 2026-11-02
CVE List
8.8
Hardy Barth cPH2 eCharge Ladestation v1.87.0 and earlier is vulnerable to Execution with Unnecessary Privileges.
- Record
CVE-2023-46360- CVSS 3.1
- 8.8 High
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-250
- Updated
- 2026-11-02
EUVDEUVD-2023-50580
8.8
Hardy Barth cPH2 eCharge Ladestation v1.87.0 and earlier is vulnerable to Execution with Unnecessary Privileges.
- Record
EUVD-2023-50580- CVSS 3.1
- 8.8 High
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-x547-pm2q-2cr6
8.8
Hardy Barth cPH2 eCharge Ladestation v1.87.0 and earlier is vulnerable to Execution with...
Hardy Barth cPH2 eCharge Ladestation v1.87.0 and earlier is vulnerable to Execution with Unnecessary Privileges.
- Record
GHSA-x547-pm2q-2cr6- CVSS 3.1
- 8.8 High
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-250
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2023-46360 is a high vulnerability (CVSS 8.8) in Hardy-barth Cph2 Echarge, published February 6, 2024. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 2.77%, the 86th percentile. No source names a fixed version.